FindMyKOL
Clinical trialNCT00074425CompletedPhase 2Interventional

BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment3,101HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The majority of HIV infected people worldwide became infected with the virus through heterosexual contact. BufferGel and PRO 2000 Gel are vaginal gels designed to prevent women from becoming infected with HIV during sexual intercourse with an HIV infected partner. This study will test the safety and effectiveness of these gels.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Gita Ramjee, PhD

    Medical Research Council, HIV Prevention Research Unit

    Study Chair
  • Groesbeck Parham, MD

    Centre for Infectious Disease Research in Zambia

    Study Chair
  • Irving Hoffman, PA, MPH

    School of Medicine, University of North Carolina

    Study Chair
  • Lisa Maslankowski, MD

    University of Pennsylvania

    Study Chair
  • Nancy Padian, PhD

    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco; AIDS Research Institute

    Study Chair
  • Salim Abdool Karim, MBChB, PhD

    University of KwaZulu-Natal, Centre for the AIDS Programme of Research in South Africa, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine

    Study Chair
  • Taha Taha, MD

    Johns Hopkins Bloomberg School of Public Health

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Malawi
  • University of North Carolina Lilongwe Crs

    Lilongwe, Central Region, Malawi

  • College of Med. Jhu Crs

    Blantyre, Southern Region, Malawi

South Africa
  • Chatsworth Crs

    Chatsworth, KwaZulu-Natal, South Africa

  • Med. Research Council-Hlabisa

    Durban, KwaZulu-Natal, South Africa

United States
  • 3535 Market Street Crs

    Philadelphia, Pennsylvania, United States

Zambia
  • Kamwala Clinic Crs

    Lusaka, Zambia

Zimbabwe
  • Seke South Crs

    Chitungwiza, Zimbabwe

  • Spilhaus Crs

    Harare, Zimbabwe

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BuffergelPRO 2000Placebo gel
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2005
Primary completion
30 Sept 2008
Completion
30 Sept 2008
Last update posted
8 Nov 2021
Registered enrollment
3,101
Registry id
NCT00074425

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.